From: The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials
 | Study design | Duration | Type of cinnamon & dose/day | FPG | HbA1C | ||||
---|---|---|---|---|---|---|---|---|---|
 | Baseline mean ± SD | Post intervention mean ± SD | Baseline Mean ± SD | Post intervention ± SD | |||||
1 | Khan et al [58] | Single-blind RCT | 40 days intervention 20 days washout | C.cassia powder 1 g,3 g,6 g | Placebo | 13.77 ± 1.33 | 13.97 ± 1.23 | _ | _ |
Cinnamon | 12.0 ± 1.43 | 9.1 ± 1.40 | _ | _ | |||||
2 | Mang et al [72] | Double- blind RCT | 40 days | C.cassia aqueous extract 3 g | Placebo | 8.66 ± 1.47 | 8.31 ± 1.62 | 6.71 ± 0.73 | 6.68 ± 0.7 |
Cinnamon | 9.26 ± 2.26 | 8.15 ± 1.65 | 6.86 ± 1.00 | 6.83 ± 0.83 | |||||
3 | Suppapitiporn et al [54] | Single blind RCT | 12Â weeks | C.cassia powder 1.5Â g | Placebo | _ | _ | 8.14 | 7.76 |
Cinnamon | _ | _ | 8.06 | 7.87 | |||||
4 | Vanschoonbe et al [55] | Double-blind RCT | 6 weeks | C.cassia powder 1.5 g | Placebo | 8.28 ± 0.33 | 8.07 ± 0.36 | 7.1 ± 0.2 | 7.2 ± 0.2 |
Cinnamon | 8.37 ± 0.64 | 7.91 ± 0.71 | 7.4 ± 0.3 | 7.5 ± 0.3 | |||||
5 | Blevins et al [56] | Double-blind RCT | 3Â months | C.cassia powder 1Â g | Placebo | 8.04 | 8.02 | 7.1 | 7.2 |
Cinnamon | 7.38 | 6.84 | 7.2 | 7.4 | |||||
6 | Crawford [57] | Randomized placebo controlled trial (no blind/open) | 90 days | C.cassia powder 1 g | Placebo | _ | _ | 8.28 ± 1.3 | 7.91 ± 1.5 |
Cinnamon | _ | _ | 8.47 ± 1.8 | 7.64 ± 1.7 | |||||
7 | Akilen et al [60] | Double-blind RCT | 12 weeks | C.cassia powder 2 g | Placebo | 8.77 ± 2.59 | 8.74 ± 3.11 | 8.55 ± 1.82 | 8.68 ± 1.83 |
Cinnamon | 8.82 ± 3.45 | 8.04 ± 3.10 | 8.22 ± 1.16 | 7.86 ± 1.42 | |||||
8 | Anderson et al [20] | Randomized placebo controlled trial | 2 months | C.cassia(CinSulin) 500 mg | Placebo | 8.57 ± 0.32 | 8.44 ± 0.34 | _ | _ |
Cinnamon | 8.85 ± 0.36 | 8.19 ± 0.29 | _ | _ |